MCDERMOTT WILL & SCHULTE LLP for SURESCRIPTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KAREN SEALANDER | — |
| SCOTT AARON WEINSTEIN | — |
Science/Technology SCI
Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KAREN SEALANDER | — |
| SCOTT AARON WEINSTEIN | — |
Medicare/Medicaid MMM
Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards. Efforts to ensure timely implementation of the SUPPORT Act requirement for electronic prescribing of controlled substances in the Medicare Part D program beginning January 1, 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KAREN SEALANDER | — |
| SCOTT AARON WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.